Prosecution Insights
Last updated: October 02, 2026
Application No. 18/578,443

HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONS

Final Rejection §103
Filed
Jan 11, 2024
Priority
Jul 15, 2021 — EU 21185950.9 +1 more
Examiner
MAEWALL, SNIGDHA
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Conopco, Inc. d/b/a Unilever
OA Round
2 (Final)
59%
Grant Probability
Moderate
3-4
OA Rounds
8m
Est. Remaining
69%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
630 granted / 1072 resolved
-1.2% vs TC avg
Moderate +10% lift
Without
With
+10.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
48 currently pending
Career history
1124
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
52.2%
+12.2% vs TC avg
§102
8.5%
-31.5% vs TC avg
§112
18.6%
-21.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1072 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Previous Rejections Applicants' arguments, filed 06/19/26, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim 22 is objected to for not ending in a period after the sentence. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-8, 10, 16 and 21-25 are rejected under 35 U.S.C. 103 as being unpatentable Mould et al. (WO 94/16680) in view of Dixon et al. (GB2297762) and further in view of Hutton et al. (US PG Pub. 2018/0098923A1). Mould discloses a hydratable concentrated surfactant personal washing composition comprising 36 wt% sodium laureth ether sulphate (SLES) anionic surfactant, 9 wt% cocamidopropyl betaine (CAPB) cosurfactant (claim 2), 2 wt% sodium chloride ("a "viscosity modifier" and a "metal chloride" and 49.1 wt% water to balance, the foregoing amounts being within the ranges recited by claim 1 and which results in a weight ratio of anionic surfactant to cosurfactant of 36:9 or 4:1, which is within the ranges of claims 1. The composition further may comprise a preservative such as sodium benzoate in the amount of 0.5-5 wt% (page 9, first two paragraphs). The use of 3 wt% sodium benzoate, 36% sodium laureth sulphate, and 9 wt% cocamidopropyl betaine results in a ratio of 3:45 or 1:15. The composition is in a lamellar phase (page 3, lines 12-13). The claimed viscosity is not taught by the reference. Dixon discloses personal cleansing compositions such as shampoos comprising surfactants (Abstract) such as betaines or sodium laureth sulfates (page 10) and additional ingredients such as sodium benzoate as a preservative (page 18, 1st full paragraph) and ethylene diaminetetraacetic acid as a calcium and magnesium ion sequestrant to provide lather boosting properties under hard water usage conditions (paragraph bridging pages 17-18). The composition may be lamellar (page 9, 1st paragraph). The pH of the composition is adjusted to about 4-8 using a buffer system (page 18, 2ⁿᵈ full paragraph). The compositions have a viscosity of 10,000-40,000 cps (page 2, last paragraph). It would have been obvious to one of ordinary skill in the art at the effective filing date of the present invention to modify the personal washing composition of Mould by selecting a viscosity and pH within the range of claim 1, because Dixon teaches that personal cleansing compositions comprising betaines, sodium laureth sulfates, and/or sodium benzoate suitably may have a viscosity and pH within the claimed range such that the skilled artisan reasonably would have expected that such viscosities and pH values would be appropriate for the Mould personal cleansing composition. Discovering optimum or working ranges involves only routine skill in art in cases where the general conditions of a claim are disclosed in the prior art. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). The references discussed above do not teach use of the polyols. Hutton et al. discloses a personal care compositions substantially free of sulfated surfactants and containing a gel network, see title. Hutton et al. teaches a personal care composition free of sulfated surfactants, see [0004]. The reference discloses aqueous compositions comprising sodium cocoyl isethionate (a sulfate free anionic surfactant as claimed in subsection a) of claim1), disodium laureth sulfosuccinate, sodium lauroyl sarcosinate, cocamidopropyl betaine (amphoteric surfactant as claimed in instant claim 1 in subsection b)), ethylene glycol distearate, disodium EDTA, decyl glucoside, sodium chloride and sodium xylene sulfonate, which is one of the well-known hydrotopes, see tables (tables 3 and 4). Surfactant like taurate can be added, see [0199]. Paragraph [0168] specifies that sodium chloride as well as sodium xylene sulfonates are two possible viscosity modifiers. Suitable suspending agents taught are hydroxy ethyl cellulose, hydroxypropyl methyl cellulose, starch-based polymers such as carboxymethyl starch and also starches (rice, corn, potato and wheat), see [0162[-[0163]. (reads on the claimed first viscosity modifiers). The reference teaches use of suspending agents for modifying the viscosity of the compositions ranging from about 0.1% to about 10% by weight of the compositions, see [0158]. The amount of first viscosity modifier overlaps with the claimed amount. The prior art does not disclose the exact claimed values, but does overlap: in such instances even a slight overlap in range establishes a prima facie case of obviousness. MPEP 2144.05 A. Accordingly, since an overlap plainly exists here, it would have been obvious to have selected values within the overlap, consistent with the reasoning of the obviousness above. Liquid carrier from about 20% to about 95% can be added including water, see [0070] and [0072].The reference teaches that rheology modifiers can be added, see [0074] and [0168] and the personal care composition can have an appropriate viscosity and rheology, see [0071]. Additional agents such as propylene glycol can be added, see [0148]. Propylene glycol reads on polyol as claimed. Suitable humectants such as polyhydric alcohols can be added including glycerin, sorbitol, propylene glycol and the amount of the humectants ranges from about 0.1% to about 20%, see [0160] and [0159]. Thus, the reference teaches use of polyol (which reads on the second viscosity modifier). Preservatives can be added, see [0172]. The reference teaches pH adjusting agents can be added, see [0074]. The reference teaches that the charge densities can be measured at the pH of intended use of the personal care composition. (e.g., at about pH 3 to about pH 9; or about pH 4 to about pH 8), see [0078]. Lamellar form of the composition is taught in [0046/47] and [0053]. Isotropic formation is taught in [0048]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have utilized the additional agents such as propylene glycol wherein the propylene glycol reads on polyol as claimed and as taught by Hutton et al. One of ordinary skill would have been motivated to do so because Hutton while teaching personal care composition and various surfactants teaches use of viscosity modifiers including cellulose and polyols for modifying viscosities of the composition. Suitable humectants such as polyhydric alcohols can be added including glycerin, sorbitol, propylene glycol and the amount of the humectants ranges from about 0.1% to about 20%, see [0160] and [0159]. Thus, the reference teaches use of polyol (which reads on the second viscosity modifier). Generally, it is prima facie obvious to select a known material for incorporation into a composition, based on its recognized suitability for its intended use. See MPEP 2144.07. Applicant’s arguments are moot in view of new rejections made above necessitated by claim amendments. Action is final Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to SNIGDHA MAEWALL whose telephone number is (571)272-6197. The examiner can normally be reached Monday thru Friday; 8:30 AM to 5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana S Kaup can be reached at 571-272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SNIGDHA MAEWALL/Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Jan 11, 2024
Application Filed
Mar 19, 2026
Non-Final Rejection mailed — §103
Jun 19, 2026
Response Filed
Aug 31, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746304
NANOCOMPOSITE FIBERS WITH A DRAMATIC REDUCTION IN HUMAN PLASMA COAGULATION TIME
5y 2m to grant Granted Sep 29, 2026
Patent 12734497
HIGH AMYLOSE STARCH BASED CAPSULES AND METHOD OF MAKING SAME
5y 4m to grant Granted Sep 15, 2026
Patent 12733639
HESPERALOE EXTRACT FOR FOLIAR USE
2y 9m to grant Granted Sep 15, 2026
Patent 12728077
TOOTH MINERALIZATION SOLUTION AND MINERALIZATION METHOD THEREOF
4y 10m to grant Granted Sep 08, 2026
Patent 12721926
MEDICAL ARTICLE WITH BACKING
5y 3m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
59%
Grant Probability
69%
With Interview (+10.5%)
3y 4m (~8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1072 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month